• CVS: +3%; added four new board members, including Larry Robbins from Glenview Capital, expanding to 16 members; upgraded by Wells Fargo.

• FOUR: +4%; to join S&P MidCap 400 in place of RCM on November 20.

• HOOD: +6%; upgraded to Buy by Needham due to expected benefits from Trump’s policy changes at SEC.

• LBRT: +2%; stock up with Chris Wright, a fracking advocate, nominated for Energy Secretary.

• MBI: +10%; upgraded to Outperform by KBW with a new $9 target after favorable legal and earnings news.

• SMCI: +9%; plans to meet Nasdaq compliance requirements for continued listing.

• TSLA: +8%; due to Trump team’s interest in autonomous vehicle regulations.

• WOLF: +5%; CEO Gregg Lowe ousted, Thomas Werner steps in as Executive Chairman during CEO search.

Stock Laggards Brief:

• BIIB: -1%; downgraded to Hold by Needham, with no expected upside in the next year.

• CMAX: -55%; filed for bankruptcy with $693M in debt, $390M in assets.

• LLY: -4%; continues to decline with other obesity/healthcare stocks.

• MARA: -6%; issuing $700M in convertible notes.

• NGNE: -35%; halted development of high-dose gene therapy due to serious side effect.

• PLTR: -9%; despite being a top S&P performer YTD, sees significant drop.

• UBER & $LYFT: -6%; both affected by news of potential regulations for autonomous vehicles.